Eurand to Present At Lazard Capital Markets 4th Annual Healthcare Conference
20. November 2007 08:30 ET
|
Eurand N.V.
AMSTERDAM, The Netherlands, Nov. 20, 2007 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based...
Eurand Reports Third Quarter 2007 Key Achievements and Financial Results
09. November 2007 08:04 ET
|
Eurand N.V.
Highlights:
----------
- Cephalon, Inc. announced in August 2007 it had signed an
agreement to acquire Amrix(r) (cyclobenzaprine HCl), a product
developed by Eurand, from ECR...
Eurand Announces Third Quarter 2007 Financial Results Conference Call
17. Oktober 2007 08:48 ET
|
Eurand N.V.
MILAN, Italy, Oct. 17, 2007 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX) will host a conference call on Friday, November 9, 2007 at 8:00 AM Eastern Daylight Time, 2:00 PM Central European Time...
Eurand to Host Official Ceremony for Facility Expansion
27. September 2007 08:45 ET
|
Eurand N.V.
DAYTON, Ohio, Sept. 27, 2007 (PRIME NEWSWIRE) -- Eurand, N.V. (Nasdaq:EURX) announced today that Eurand, Inc. will host a formal ceremony to mark the groundbreaking of its facility expansion in...
Eurand to Present At the UBS Global Life Sciences Conference
18. September 2007 08:30 ET
|
Eurand N.V.
MILAN, Italy and DAYTON, Ohio, Sept. 18, 2007 (PRIME NEWSWIRE) -- Eurand (Nasdaq:EURX) announced today that it will present at the upcoming UBS Global Life Sciences Conference at the Grand Hyatt Hotel...
Eurand Appoints Two New Members to Its Board of Directors
13. September 2007 09:38 ET
|
Eurand N.V.
AMSTERDAM, Sept. 13, 2007 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX) announced today the appointment of Angelo C. Malahias and Rolf A. Classon to the Eurand Board of Directors.
Mr. Malahias and...
Eurand Reports First Half 2007 Key Achievements and Financial Results
03. August 2007 08:00 ET
|
Eurand N.V.
Highlights:
-- Announced clinically and statistically significant results from two
Phase III studies of lead product candidate, Zentase(tm), in April
2007
-- Granted fast track...